SC 13G/A | 2019-02-12 | Flynn James E | BIOCRYST PHARMACEUTICALS INC | 6,910,789 | 6.3% | EDGAR |
SC 13G/A | 2019-02-11 | VANGUARD GROUP INC | BIOCRYST PHARMACEUTICALS INC | 5,872,229 | 5.4% | EDGAR |
SC 13G/A | 2019-02-11 | JANUS HENDERSON GROUP PLC | BIOCRYST PHARMACEUTICALS INC | 12,302,555 | 11.2% | EDGAR |
SC 13G/A | 2019-02-04 | BlackRock Inc. | BIOCRYST PHARMACEUTICALS INC | 8,849,427 | 8.1% | EDGAR |
SC 13G | 2019-01-11 | GREAT POINT PARTNERS LLC | BIOCRYST PHARMACEUTICALS INC | 7,622,256 | 7.0% | EDGAR |
SC 13G/A | 2018-08-06 | RA CAPITAL MANAGEMENT, LLC | BIOCRYST PHARMACEUTICALS INC | 9,234,692 | 8.5% | EDGAR |
SC 13D/A | 2018-07-31 | GREAT POINT PARTNERS LLC | BIOCRYST PHARMACEUTICALS INC | 7,478,275 | 7.6% | EDGAR |
SC 13G/A | 2018-07-10 | JANUS HENDERSON GROUP PLC | BIOCRYST PHARMACEUTICALS INC | 11,096,183 | 11.2% | EDGAR |
SC 13D/A | 2018-06-20 | GREAT POINT PARTNERS LLC | BIOCRYST PHARMACEUTICALS INC | 7,478,275 | 7.6% | EDGAR |
SC 13D | 2018-04-02 | RA CAPITAL MANAGEMENT, LLC | BIOCRYST PHARMACEUTICALS INC | 6,984,692 | 7.1% | EDGAR |
SC 13D | 2018-02-16 | GREAT POINT PARTNERS LLC | BIOCRYST PHARMACEUTICALS INC | 7,478,275 | 7.6% | EDGAR |
SC 13G/A | 2018-02-14 | VENROCK HEALTHCARE CAPITAL PARTNERS LP | BIOCRYST PHARMACEUTICALS INC | 2,851,385 | 2.9% | EDGAR |
SC 13G/A | 2018-02-14 | D. E. SHAW & CO, L.P. | BIOCRYST PHARMACEUTICALS INC | 939,473 | 1.0% | EDGAR |
SC 13G/A | 2018-02-14 | Flynn James E | BIOCRYST PHARMACEUTICALS INC | 7,213,393 | 7.3% | EDGAR |
SC 13G/A | 2018-02-14 | RTW INVESTMENTS, LP | BIOCRYST PHARMACEUTICALS INC | 3,372,674 | 3.4% | EDGAR |
SC 13G | 2018-02-14 | RA CAPITAL MANAGEMENT, LLC | BIOCRYST PHARMACEUTICALS INC | 6,984,692 | 7.1% | EDGAR |
SC 13G/A | 2018-02-13 | BAKER BROS. ADVISORS LP | BIOCRYST PHARMACEUTICALS INC | 14,057,172 | 14.3% | EDGAR |
SC 13G | 2018-02-12 | JANUS HENDERSON GROUP PLC | BIOCRYST PHARMACEUTICALS INC | 6,739,266 | 6.8% | EDGAR |
SC 13G | 2018-02-08 | VANGUARD GROUP INC | BIOCRYST PHARMACEUTICALS INC | 5,777,835 | 5.9% | EDGAR |
SC 13G/A | 2018-01-29 | BlackRock Inc. | BIOCRYST PHARMACEUTICALS INC | 7,614,280 | 7.7% | EDGAR |